novo nordisk compounded semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Semaglutide: The Drug of Today
Description
The UK has approved a once daily Wegovy semaglutide pill for weight loss, marking Europes first oral GLP-1 treatment
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.
Enjoy a tasty and delicious meal with your loved ones
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn
